Ya-Man EMS Product and Clinical NMES Research | May 2026
A roundup of papers, patents, product launches, and company announcements published in May 2026 relating to EMS (Electrical Muscle Stimulation), NMES, and FES. From the candidates checked each week, we select what matters to general readers and to people working in product planning, and add a summary, a general-audience explanation, and our own take. The explanations begin with what the research set out to establish.
If you would like to start with the fundamentals, see The EMS Textbook. For the full archive including past months, see the EMS Industry News Index (annual hub).
How to read patent documents, and what to watch out for, is covered in more detail in Patents in EMS and Beauty Devices.
In this series, papers are checked on their study conditions, patents on their scope of rights, and new products on what the manufacturer states — each separately. None of it is used to guarantee a medical or cosmetic effect.
This month at a glance
- Papers and research: 5. Participants, comparison conditions, stimulation conditions and study design are checked separately.
- Patents: 1. A published application is not the same thing as a shipped product, nor as proof of efficacy.
- Product launches and company announcements: 1. Manufacturer specifications and third-party verification are treated as distinct.
The theme this month is a single result: walking distance improved, while the circulatory measures did not move. In a randomized trial in peripheral artery disease, calf NMES significantly improved walking distance, yet showed no difference in measures of blood flow or ankle-brachial index. For anyone thinking about how foot EMS is marketed, this is unavoidable material.
Week numbering runs from Monday. Week 18 spans 27 April to 3 May, so only the May portion appears here.
Week 18 (May 1–3)
Papers and research
A pilot study of EMS in dialysis patients with lower-limb ischaemia
Published: 2026-05-01 Journal: Plastic & Reconstructive Surgery Global Open
Summary: A small pilot study applying EMS to patients receiving haemodialysis who also have lower-limb ischaemia, exploring changes in circulation and muscle strength.
Background:
The reason the question arises at all lies in the situation these patients are in. People on long-term dialysis are prone to advancing arteriosclerosis and frequently develop impaired blood flow in the legs. They are also a group for whom exercise therapy is difficult to prescribe. Dialysis itself takes up time, and where there is ischaemia in the limb, walking loads are hard to apply. If there were a way to produce muscle contraction from outside, it might fill that gap — this is the background against which EMS gets considered.
That said, applying stimulation to an ischaemic limb is itself something to be established. Before the size of any effect can be measured, there is a stage of asking whether it can be done and whether it can be done safely, and a pilot study sits there. Even where a title speaks of improvement, this remains a small study in a limited population. Results obtained in a medical environment with safety oversight cannot be generalized to household EMS use by healthy people.
Our take: Exploratory studies exist to feed into the larger trials that follow. In general-audience coverage, we settle on wording only after checking the number of participants, the comparison group, the follow-up period and the adverse events — not just the direction of the result. In particular, "it could be used even in people with ischaemia" is a different claim from "it improves blood flow." Keeping the two apart is the minimum condition for handling this kind of research.
Read the original paper (Plastic & Reconstructive Surgery Global Open)
Week 19 (May 4–10)
Product launches and company announcements
Ya-Man announces the EMS-equipped Veda Needle Spa Dual
Announced: 2026-05-05 Announced by: Ya-Man Ltd.
Summary: Ya-Man announced that its salon-oriented line will gain an EMS-equipped device for use on the scalp, face and body, supplied with two attachment types — one for the scalp and one for kneading — rolling out from 6 May 2026. Official materials state EMS output at 111% of the previous model.
Background: The figure of 111% is a comparison against the manufacturer's own earlier model, and does not directly express how the stimulation feels or how much muscle contraction occurs at the intended site. It needs to be read together with which model was compared, under what measurement conditions, over what electrode contact area, and with what output control. At the same stated output, smaller electrodes raise current density and the sensation becomes stronger; widen the contact area and the same figure feels gentler. This is why a number on its own does not make a comparison.
Our take: A design that changes the contact geometry by swapping attachments matters more in practice than a straightforward contest over peak output. From a former engineer's point of view, the next thing to check on this product is how electrode spacing and contact detection change from one body area to another. Scalp, face and body differ in skin thickness, in the presence of hair, and in how deep the muscles sit. If a single body is to cover all three, how those differences are absorbed on the attachment side is where the interest lies.
View the original announcement from the manufacturer
Papers and research
Calf NMES in peripheral artery disease: walking distance improved, circulatory measures did not
Published: 2026-05-07 Journal: European Journal of Preventive Cardiology
Summary: An editorial on the ELECTRO-PAD randomized controlled trial published in the same journal (five French university hospitals, 73 adults). The trial itself compared three months of home-based calf NMES against usual care in patients with peripheral artery disease and walking impairment. Maximal treadmill walking distance went from 148.5 m to 254.1 m in the NMES group and from 142.5 m to 175.8 m under usual care, a between-group difference of 69.9 m (95% CI 10.8–129.0; P = 0.02). Six-minute total walking distance differed by 29.6 m. Meanwhile, no difference emerged in pain-free walking distance, self-reported walking impairment, quality-of-life scores, ankle-brachial index, or measures of blood flow response at the forearm and calf.
Background:
For intermittent claudication caused by peripheral artery disease, supervised exercise therapy is known to be the most effective treatment. The problem is how few people can access it. There is no facility nearby, they cannot get there, they do not keep it up. That has driven the search for alternatives that work at home. NMES produces muscle contraction while seated, and has repeatedly come up as a candidate in this context. Earlier trials, however, were small and short — on the order of a month. ELECTRO-PAD tested it over three months across multiple centres.
As background for reading this: in this field, walking distance and circulatory measures are recorded separately, because being able to walk further is not the same as blood flow having improved. Changes in walking distance involve several factors at once — how pain is perceived, how readily the muscle fatigues, changes in gait.
Our take: The asymmetry in the results is what to read here. Walking distance improved. Ankle-brachial index did not move, and neither did the blood-flow response measures. In other words, the trial showed that people could walk further; it did not show that they could walk further because blood flow improved.
Foot EMS advertising is a space where the words "blood flow" and "circulation" spread easily. That no difference in circulatory measures emerged even under medical supervision, in people with diagnosed disease, over three months, is concrete counter-evidence against circulation claims for household products. Even in a study whose overall direction is favourable, unless you look at which measures moved and which did not, you end up lending support to a claim the evidence does not carry.
The editorial positions the 69.9 m improvement as larger than what pharmacological treatment (around 40 m) or home-based exercise (around 55 m) has shown, and smaller than supervised treadmill exercise (around 180 m). A complement rather than a replacement seems the fair reading. It goes without saying that none of this is carried over into claims about treating disease.
Read the editorial (European Journal of Preventive Cardiology)
Read the trial itself (ELECTRO-PAD RCT)
Published patent applications
Methods and systems for transcutaneous muscle stimulation (KR20260061525A)
Published: 2026-05-06 Applicant / assignee as listed: Zansors LLC
Summary: A Korean publication covering a method and system for stimulating muscle transcutaneously by placing multiple electrodes near the target muscle.
Background:
About the applicant
Filed in the name of Zansors LLC (United States). This series covered the same company's US publication US20260014372A1 (Methods and systems for transdermally stimulating a muscle) in the January 2026 edition. Since applicant, title and technical content all correspond, the present case can be taken as the Korean entry of the same family. The technical core identified in the US publication was to treat skin as an electrical capacitor and to alternate polarity, suppressing polarization at the skin surface so that adequate muscle contraction is obtained at lower voltage.
Filing and prosecution status
Priority runs back to a US provisional filed 28 July 2022 (No. 63/392,916), followed by a PCT application on 26 September 2023 (PCT/US2023/033700). The US national phase case was published in January 2026, and the present case is the Korean publication roughly four months later — consistent with sequential entry into multiple jurisdictions from a single PCT. Note that the claims of the Korean publication itself have not been verified, and the identity of the family is inferred by comparing the published documents.
Direction of the claims
On the US side, the independent claim was a method claim rather than a device claim, centred on the sequence of bringing electrodes into contact with the skin, applying a voltage of a first polarity, then applying a second voltage of the reverse polarity. Because Korean examination standards and the handling of amendments both differ, claims founded on the same PCT will not necessarily end up in the same shape as in the United States. When following a family, how much scope survived in each jurisdiction has to be checked case by case.
View the publication on Google Patents (KR20260061525A)
Week 20 (May 11–17)
Papers and research
An open randomized trial comparing individualized NMES in children with cerebral palsy
Published: 2026-05-17 Journal: Physical and rehabilitation medicine medical rehabilitation
Summary: An open randomized study in children with spastic diplegic cerebral palsy, adding individually adjusted NMES to rehabilitation and comparing spasticity, muscle strength and endurance.
Background:
In spastic cerebral palsy, the balance of tone between opposing muscles is disturbed. The straightforward idea of "strengthening the weak muscle" does not transfer cleanly, and a uniform stimulation setting may end up reinforcing excess tone. That is precisely why settings need to be decided after assessing muscle tone and motor function in each individual — which is where the framing of individualization comes from. This study set out to test whether it actually produces a difference in outcome.
As background, this is a study where several conditions overlap: children, a neurological condition, and individual adjustment. How stimulation intensity is decided and the presence of specialist supervision both shape the result, so the premises differ from self-administered use of a consumer product.
Our take: "Individualized" is an attention-grabbing word, but it is not the same as being able to pick a level. It only earns the name once it includes the step of assessing muscle tone, motor function and tolerance and changing the settings accordingly. When a product advertises "personalization" or "automatic adjustment," what it measures and what it changes is worth checking each time.
Read the original paper (Physical and rehabilitation medicine medical rehabilitation)
Week 21 (May 18–24)
Papers and research
BFR and EMS compared in low-load upper-body exercise in volleyball
Published: 2026-05-22 Journal: The Journal of Strength and Conditioning Research
Summary: A study of low-load upper-body exercise in volleyball players, examining the acute effect on subsequent performance of priming with either blood flow restriction or EMS.
Background:
It is known that applying some form of stimulus before the main effort can temporarily raise subsequent output. Conventionally this has been pursued by handling heavy loads, but in a competitive setting there are many situations where heavy loads before a match are not an option. Is there a way to get the same effect while keeping the load light? That is where blood flow restriction and EMS come in as candidates. The two work by entirely different mechanisms, but their purposes overlap in delivering a strong stimulus to the muscle without raising the weight. That is why this study placed them side by side.
The premise for reading it is that a temporary rise in performance and long-term hypertrophy or skill development are entirely separate things. Changes measured immediately afterwards, the sport in question, and the participants' training experience all need to be kept distinct.
Our take: For sports-oriented EMS, when it is used is the decisive question. Coverage needs to state whether a study placed it in the warm-up, the main effort or the recovery phase, and must not stretch the finding into long-term everyday effects. Reading a finding about pre-exercise priming as "wear it daily and you will get stronger" substitutes one claim for another on a different time scale.
Read the original paper (The Journal of Strength and Conditioning Research)
Week 22 (May 25–31)
Papers and research
An exploratory comparison of TENS, EMS, exercise and heat for low back pain
Published: 2026-05-29 Journal: European Journal of Pain
Summary: A randomized exploratory clinical trial in low back pain comparing four different interventions: TENS, EMS, exercise and heat.
Background:
There are many conservative options used for low back pain. Yet while each has been examined individually, few studies have placed them side by side under the same conditions. Clinicians and buyers alike face the question of which to choose, and the basis for comparison is missing. Exploratory though it is, putting several interventions into a single trial is meant to fill that gap.
As background, these act at different points. TENS is nerve stimulation aimed at pain, EMS produces muscle contraction, and exercise and heat are different again. Because the purpose and the point of action differ even when the sensation is similar, choosing the right mode matters.
Our take: This offers a useful axis of comparison when evaluating combination devices such as heated EMS belts. Multi-mode products tend to be sold as having everything, but in the framework of this study, all that means is that interventions of different natures have been gathered into one unit. That said, improvement of low back pain is a medical claim, and it is important not to carry it over directly into claims for a household consumer product.